Answer: BPC-157 has been studied most for gut and inflammatory bowel conditions, wound and tissue repair, tendon and joint recovery, collagen support for skin, and systemic inflammation, though much of this evidence is preclinical
Patients with severe absorption issues and deficiencies often have to inject more often
Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 16117343] PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context
Potential Side Effects Reduces the production of new fat Boosts the number of calories burned Increases metabolism and promotes cartilage and bone healing Controls blood sugar Effectiveness of AOD 9604 According to a study on the metabolic effects of AOD 9604 in obese Zucker rats, the therapy significantly reduced body weight increase in comparison to the control group by more than 50%
Capsules may also reduce handling complexity compared with injectable formats because they dont have the same laboratory preparation considerations
Values summarised from cited preclinical studies (see references below)